Restricted accessResearch articleFirst published online 2024-12
A new bithiophene inhibited amyloid-β accumulation and enhanced cognitive function in the hippocampus of aluminum-induced Alzheimer's disease in adult rats
Alzheimer's disease (AD) is a progressive and irreversible neurological disorder that gradually deteriorates an individual's ability to carry out even the simplest tasks.
Objective
This study was undertaken to investigate the potential therapeutic efficacy of a novel bithiophene in a rat model of aluminum-induced AD pathology.
Methods
A total of 108 adult male albino rats weighing 160 ± 20 g, were randomly assigned to six groups: (1) a control group administered DMSO, (2) group receiving a high dose of bithiophene (1 mg/kg), (3) a model group received AlCl3 (100 mg/kg), those rats were then treated by either (4) bithiophene low dose (0.5 mg/kg), (5) high dose (1 mg/kg), or (6) memantine (20 mg/kg).
Results
Low dose bithiophene treatment was a promising strategy for mitigating oxidative stress and improving synaptic plasticity. This was demonstrated by reductions in malondialdehyde level, and increased activities of superoxide dismutase and catalase, and elevated glutathione content. Likewise, low dose bithiophene enhanced synaptic plasticity through a reduction in excitatory glutamate and norepinephrine levels, while increasing dopamine. Moreover, bithiophene significantly downregulated the expression of GSAP, GSK3-β, and p53, which are implicated in AD progression. This treatment also decreased caspase 3 and amyloid-β (Aβ1–42) accumulation in the hippocampus. Finally, behavioral assessments revealed that low dose bithiophene significantly enhanced learning abilities, as proved by Morris water maze.
Conclusions
Low dose bithiophene mitigated AD through ameliorating oxidative stress, promoting synaptic plasticity, inhibiting the Aβ accumulation, and enhancing the cognitive functions in a rat model.
VinzeSChodoshJLeeM, et al.The national public health response to Alzheimer's disease and related dementias: origins, evolution, and recommendations to improve early detection. Alzheimers Dement2023; 19: 4276–4286.
2.
LeeDKimSKimK. International R&D collaboration for a global aging society: focusing on aging-related national-funded projects. Int J Environ Res Public Health2020; 17: 8545.
3.
SinjaSS. The role of beta-amyloid in Alzheimer's disease. Med Clin2002; 86: 629–639.
4.
SmallSADuffK. Linking Aβ and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron2008; 60: 534–542.
5.
PimplikarSW. Neuroinflammation in Alzheimer’s disease: from pathogenesis to a therapeutic target. J Clin Immunol2014; 34: 64–69.
6.
Ferreira-VieiraHGuimaraesMSilvaIR, et al.Alzheimer's disease: targeting the cholinergic system. Curr Neuropharmacol2016; 14: 101–115.
7.
Dams-O'ConnorKBellgowanPSFCorriveauR, et al.Alzheimer's disease-related dementias summit 2019: national research priorities for the investigation of traumatic brain injury as a risk factor for Alzheimer's disease and related dementias. J Neurotraumatol2021; 38: 3186–3194.
8.
MahdiAATripathiSNeerjaJ, et al.Aluminium mediated oxidative stress: possible relationship to cognitive impairment of Alzheimer's type. Ann Neurosci2010; 13: 18–24.
9.
WaltonJR. An aluminum-based rat model for Alzheimer’s disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J Inorg Biochem2007; 101: 1275–1284.
10.
WaltonJR. Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology2006; 27: 385–394.
11.
WisniewskiHMWenGY. Aluminium and Alzheimer's disease. In: DJCWhelanJ (eds) Ciba foundation symposium 169-aluminium in biology and medicine: aluminium in biology and medicine: ciba foundation symposium. Chichester, UK: John Wiley & Sons, 2007, pp.142–164.
12.
HussinWAIsmailMAEl-SayedWM. Novel 4-substituted phenyl-2,2′-bichalcophenes and aza-analogs as antibacterial agents: a structural activity relationship. Drug Des Devel Ther2013; 7: 185–193.
13.
El-SayedWMHussinWA. Antimutagenic and antioxidant activity of novel 4-substituted phenyl-2,2′-bichalcophenes and aza-analogs. Drug Des Devel Ther2013; 7: 73–81.
14.
HussinWAIsmailMAAlzahraniAM, et al.Evaluation of the biological activity of novel monocationic fluoroaryl-2,2′-bichalcophenes and their analogues. Drug Des Devel Ther2014; 8: 963–972.
15.
IsmailMAArafaRKYoussefMM, et al.Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues. Drug Des Devel Ther2014; 8: 1659–1672.
16.
IsmailMAAbdelwahabGAHamamaWS, et al.Synthesis and antiproliferative activity of new thienylnicotinamidines: pro-apoptotic profile and cell cycle arrest of HepG2 cells. Arch Pharm2022; 355: e2100385.
17.
El-MetwallySAKhalilAKEl-NaggarAM, et al.Novel tetrahydrobenzo [b] thiophene analogues exhibit anticancer activity through enhancing apoptosis and inhibiting tyrosine kinase. Anti-Cancer Agents Med Chem2018; 18: 1761–1769.
18.
IsmailMANegmAArafaRK, et al.Anticancer activity, dual prooxidant/antioxidant effect, and apoptosis induction profile of new bichalcophene-5-carboxamidines. Eur J Med Chem2019; 169: 76–88.
19.
IsmailMAYoussefMMArafaRK, et al.Synthesis and antiproliferative activity of monocationic arylthiophene derivatives. Eur J Med Chem2017; 126: 789–798.
20.
Al-ShunSAEl-SendunyFFIsmailMA, et al.Anticancer activity of new cationic arylthiophenes against hepatocellular carcinoma. Life Sci2021; 269: e119028.
21.
RameshMAcharyaAMuruganNA, et al.Thiophene-based dual modulators of Aβ and tau aggregation. Chem Bio Chem2021; 22: 3348–3357.
22.
YoussefMMAl-OmairMAIsmailMA. Synthesis, DNA affinity, and antimicrobial activity of 4-substituted phenyl-2,2′-bichalcophenes and aza-analogues. Med Chem Res2012; 21: 4074–4082.
23.
LinWTChenRCLuWW, et al.Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer's disease rat model. Sci Reports2015; 5: 9671.
24.
NakamuraSMurayamaNNoshitaT, et al.Cognitive dysfunction induced by sequential injection of amyloid-β and ibotenate into the bilateral hippocampus; protection by memantine and MK-801. Eur J Pharmacol2006; 548: 115–122.
25.
MorrisRG. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods1984; 11: 47–60.
26.
El-MaraghiEFAbdel-FattahKISolimanSM, et al.Taurine provides a time-dependent amelioration of the brain damage induced by γ-irradiation in rats. J Haz Mat2018; 359: 40–46.
27.
BeutlerEDuronOKellyBM. Improved method for the determination of blood glutathione. J Lab Clin Med1963; 61: 882–888.
28.
NishikimiMRaoNAYagiK. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophysical Res Commun1972; 46: 849–854.
29.
SinhaAK. Colorimetric assay of catalase. Anal Biochem1972; 47: 389–394.
30.
LowryORosebroughNFarrAL, et al.Protein measurement with the Folin phenol reagent. J Biol Chem1951; 193: 265–275.
31.
ShahatASHassanWAEl-SayedWM. N-Acetylcysteine and safranal prevented the brain damage induced by hyperthyroidism in adult male rats. Nutr Neurosci2022; 25: 231–245.
32.
GorunVProinovIBăltescuV, et al.Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations. Anal Biochem1978; 86: 324–326.
33.
El-AzmaMHEl-BeihNMEl-ShamyKA, et al.Pumpkin seed oil and zinc attenuate chronic mild stress perturbations in the cerebral cortex of rats. Nutr Food Sci2022; 52: 1070–1082.
34.
CuiTQiuHMHuangD, et al.Abnormal levels of seven amino neurotransmitters in depressed rat brain and determination by HPLC-FLD. Biomed Chromatogr2017; 31: e3937.
35.
HayatMA. Antigens and antibodies. In: HayatMA (eds) Microscopy, immunohistochemistry, and antigen retrieval methods for light and electron microscopy. New York, NY: Kluwer Academic, 2002, pp.31–51.
36.
XuLZhangWLiuX, et al.Circulatory levels of toxic metals (aluminum, cadmium, mercury, lead) in patients with Alzheimer’s disease: a quantitative meta-analysis and systematic review. J Alzheimers Dis2018; 62: 361–372.
37.
ReddyMKWuLKouW, et al.Superoxide dismutase loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl Biochem Biotechnol2008; 151: 565–577.
38.
JangraAKasbePPandeySN, et al.Hesperidin and silibinin ameliorate aluminum-induced neurotoxicity: modulation of antioxidants and inflammatory cytokines level in mice hippocampus. Biol Trace Element Res2015; 168: 462–471.
39.
HuangTTLeuDZouY. Oxidative stress and redox regulation on hippocampal-dependent cognitive functions. Arch Biochem Biophys2015; 576: 2–7.
40.
RibasVGarcía-RuizCFernández-ChecaJC. Glutathione and mitochondria. Front Pharmacol2014; 5: 102805.
41.
AbdEl-RaoufKFarragHSHRashedR, et al.New bithiophene derivative attenuated Alzheimer's disease induced by aluminum in a rat model via antioxidant activity and restoration of neuronal and synaptic transmission. J Trace Elem Med Biol2024; 82: 127352.
42.
FortesACAlmeidaAACOliveiraGAL, et al.Is oxidative stress in mice brain regions diminished by 2-[(2, 6-dichlorobenzylidene) amino]-5, 6-dihydro-4H-cyclopenta [b] thiophene-3-carbonitrile?Oxid Med Cell Longev2013; 2013: e194192.
43.
HaridevamuthuBManjunathanTGuruA, et al.Amelioration of acrylamide induced neurotoxicity by benzo[b]thiophene analogs via glutathione redox dynamics in zebrafish larvae. Brain Res2022; 1788: e147941.
44.
ZattaPIbn-Lkhayat-IdrissiMZambenedettiP, et al.In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res Bull2002; 59: 41–45.
45.
SinghTGoelRK. The neuroprotective effect of Allium cepa L. in aluminium chloride induced neurotoxicity. Neurotoxicology2015; 49: 1–7.
46.
JonesDNRaghantiMA. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J Chem Neuroanatomy2021; 114: e101957.
47.
AnadozieSOEffiomDOAdewaleOB, et al.Hibiscus sabdariffa synthesized gold nanoparticles ameliorate aluminum chloride induced memory deficits through inhibition of COX-2/BACE-1 mRNA expression in rats. Arab J Chem2023; 16: 1–14.
48.
RiedelGPlattBMicheauJ. Glutamate receptor function in learning and memory. Behav Brain Res2003; 140: 1–47.
49.
StewardOWorleyP. Local synthesis of proteins at synaptic sites on dendrites: role in synaptic plasticity and memory consolidation. Neurobiol Learn Mem2002; 78: 508–527.
50.
CoyleJTPuttfarckenP. Oxidative stress, glutamate, and neurodegenerative disorders. Science1993; 262: 689–695.
FengJZhangCLischinskyJE, et al.A genetically encoded fluorescent sensor for rapid and specific in vivo detection of norepinephrine. Neuron2019; 102: 745–761.
53.
MilaneseMLkhayatMIZattaP. Inhibitory effect of aluminum on dopamine β-hydroxylase from bovine adrenal gland. J Trace Elem Med Biol2001; 15: 139–141.
54.
ZattaPZambenedettiPMilaneseM. Activation of monoamine oxidase type-B by aluminum in rat brain homogenate. Neuroreports1999; 10: 3645–3648.
55.
LiZYuZZhangJ, et al.Impact of rivastigmine on cognitive dysfunction and falling in Parkinson's disease patients. Eur Neurol2015; 74: 86–91.
56.
JacobsBLAzmitiaEC. Structure and function of the brain serotonergic system. Physiological Rev1992; 72: 165–229.
57.
JinCWangJWangY, et al.Modulation of amyloid precursor protein cleavage by γ-secretase activating protein through phase separation. Proc Natl Acad Sci U S A2022; 119: e2122292119.
58.
MathiyazahanDBThenmozhiAJManivasagamT. Protective effect of black tea extract against aluminium chloride-induced Alzheimer's disease in rats: a behavioural, biochemical, and molecular approach. J Funct Foods2015; 16: 423–435.
59.
HooperCKillickRLovestoneS. The GSK3 hypothesis of Alzheimer’s disease. J Neurochem2008; 104: 1433–1439.
60.
Llorens-MartínMJuradoJHernándezF, et al.GSK-3β, a pivotal kinase in Alzheimer disease. Front Mole Neurosci2014; 7: 46.
61.
MedinaMGarridoJJWandosellFG. Modulation of GSK-3 as a therapeutic strategy on tau pathologies. Front Mol Neurosci2011; 4: 24.
62.
PlanelESunXTakashimaA. Role of GSK-3β in Alzheimer's disease pathology. Drug Dev Res2002; 56: 491–510.
63.
CalissanoPMatroneCAmadoroG. Apoptosis and in vitro Alzheimer’s disease neuronal models. Commun Integr Biol2009; 2: 163–169.
64.
RothKAD'SaC. Apoptosis and brain development. Ment Retard Dev Disabil Res Rev2001; 7: 261–266.
65.
WójcikPJastrzębskiMKZiębaA. Caspases in Alzheimer’s disease: mechanism of activation, role and potential treatment. Mol Neurobiol2024; 61: 4834–4853.
66.
JembrekMJSladeNHofPR, et al.The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease. Progress Neurobiol2018; 168: 104–127.
67.
RamadanDAliMYahyaS, et al.Correlation between antioxidant/antimutagenic and antiproliferative activity of some phytochemicals; a prediction model. Anti-Cancer Agents Med Chem2019; 12: 1481–1490.
68.
RohnTTHeadE. Caspase activation in Alzheimer's disease: early to rise and late to bed. Rev Neurosci2008; 19: 383–394.
69.
MahmoudAAEl-SayedWM. The anti-proliferative activity of anisosciadone: a new guaiane sesquiterpene from Anisosciadium lanatum. Anti-Cancer Agents Med Chem2019; 19: 1114–1119.
70.
IsmailMMSolimanDHSabourR, et al.Synthesis of new arylazopyrazoles as apoptosis inducers: candidates to inhibit proliferation of MCF-7 cells. Archiv der Pharmazie2021; 354: e2000214.
71.
SalemMSHusseinRAEl-SayedWM. Substitution at phenyl rings of chalcone and schiff base moieties accounts for their antiproliferative activity. Anti-Cancer Agents Med Chem2019; 19: 620–626.
72.
GhribiOHermanMMForbesMS, et al.GDNF Protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochondrial Bax translocation. Neurobiol Dis2001; 8: 764–773.
73.
Al-KahtaniMA. Effect of both selenium and biosynthesized nano-selenium particles on cadmium-induced neurotoxicity in albino rats. Human Exp Toxicol2020; 39: 159–172.
74.
AbdEl-RaoufKEl-GanzuriMAEl-SayedWM. Therapeutic effects of a new bithiophene against aluminum-induced Alzheimer’s disease in a rat model: pathological and ultrastructural approach. Tissue Cell2024; 90: 102529.
75.
SunXChenWDWangYD. β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease. Front Pharmacol2015; 6: e164010.
76.
MorrisRG. Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci1989; 9: 3040–3057.
77.
SethiPJyotiAHussainE, et al.Curcumin attenuates aluminium-induced functional neurotoxicity in rats. Pharmacol Biochem Behavior2009; 93: 31–39.
